----item----
version: 1
id: {7DC193FC-4597-4974-8FB1-3E5C000B259C}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/09/29/AcelRx Pharmaceuticals Appoints VicePresident Of Commercial Strategy
parent: {5398E1AD-3008-4257-BE24-65E2DBD2F089}
name: AcelRx Pharmaceuticals Appoints VicePresident Of Commercial Strategy
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 56c4168f-a186-46a8-8029-fc517e4b0e30

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 77

{B3122C5E-FF3F-438A-9C93-1B54DC1286A5}|{9557EF58-727F-4007-9C73-6232F381DFF1}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 69

AcelRx Pharmaceuticals Appoints Vice-President Of Commercial Strategy
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 68

AcelRx Pharmaceuticals Appoints VicePresident Of Commercial Strategy
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 517

<p>AcelRx Pharmaceuticals, a company focused on acute pain, has appointed Gina Ford vice-president of commercial strategy. She has worked with the company since 2013 as consultant and was involved in the development of a commercial strategy for <i>Zalviso</i> (sufentanil), which is now approved in Europe. Prior to joining AcelRx, Ford ran her own consulting firm. She was also president of Accesia (a wholly owned subsidiary of Patient Services, Inc.) and has also held various leadership positions at Ipsen.</p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 514

<p>AcelRx Pharmaceuticals, a company focused on acute pain, has appointed Gina Ford vice-president of commercial strategy. She has worked with the company since 2013 as consultant and was involved in the development of a commercial strategy for <i>Zalviso</i> (sufentanil), which is now approved in Europe. Prior to joining AcelRx, Ford ran her own consulting firm. She was also president of Accesia (a wholly owned subsidiary of Patient Services, Inc.) and has also held various leadership positions at Ipsen.</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 68

AcelRx Pharmaceuticals Appoints VicePresident Of Commercial Strategy
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150929T130001
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150929T130001
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150929T130001
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029957
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 69

AcelRx Pharmaceuticals Appoints Vice-President Of Commercial Strategy
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{202BB75B-8718-40FC-96EC-851DBBB43362}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

360721
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042459Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

56c4168f-a186-46a8-8029-fc517e4b0e30
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042459Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
